Bringing Research Together,
Advancing Innovation

Welcome to the National Unit for Full-Stage Development of
Immune Cell Gene Therapy (NDIT).
Thank you for visiting our website.

NDIT was established to advance the development of innovative immune cell gene therapies for solid tumors and other difficult-to-treat cancers.
Through support for the full-stage development of CAR-T, TCR-T, TIL, and other next-generation cell therapies, we are committed to helping translate promising research into new treatment opportunities for patients.
As a national R&D initiative supported by multiple government ministries, NDIT brings together researchers, clinicians, universities, hospitals, and industry partners in a collaborative research ecosystem. By sharing expertise and working toward common goals, we aim to accelerate innovation and strengthen Korea's capabilities in immune cell gene therapy.
We will continue to foster collaboration, support outstanding research, and contribute to the development of safe and effective therapies that can benefit patients.

Thank you for your continued interest and support.

National Unit for Full-Stage Development of Immune Cell Gene Therapy

Director Hyun Seok Um